Close Menu

Beckman Coulter

NEW YORK (GenomeWeb News) – AB Sciex today announced that it is combining its Eksigent chromatography business with the capillary electrophoresis unit of its fellow Danaher stablemate Beckman Coulter.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration this week gave 510(k) clearance to Beckman Coulter's Access AccuTnl+3 troponin l assay for use on the company's Access 2 immunoassay system.

Minneapolis – Thermo Fisher Scientific made a splash at this week's American Society of Mass Spectrometry annual meeting with the launch of its hi-res Fusion instrument (

NEW YORK (GenomeWeb News) – Beckman Coulter Genomics today said that three states have licensed its BRAF assay, expanding the availability of the test.

The story has been updated to include commments from Danaher's conference call.

Beckman Coulter Genomics is now offering RNA-seq services using Illumina's TruSeq RNA sample prep kits and HiSeq 2000 in conjunction with Beckman Coulter's Biomek liquid handling platform.

The Molecular Diagnostics Research Group at the National University of Ireland, Galway, has ramped up its commercial activity in recent months in an attempt to market the group's innovations — particularly novel nucleic acid targets for infectious diseases — as well as its assay design and

US President Barack Obama has named Institute for Systems Biology president Leroy Hood and Frederick Hawthorne, director of the Institute of Nano and Molecular Medicine at the University of Missouri at Columbia,

Danish diagnostic technology developer Atonomics has published a paper describing its proprietary nested PCR technology and has demonstrated its ability to simultaneously detect multiple yeast and bacterial nucleic acid targets more quickly, and with a lower limit of detection, t

NEW YORK (GenomeWeb News) – Danaher today reported sales in its Life Sciences & Diagnostics segment more than doubled in the second quarter from a year ago, while total revenues grew 25 percent.

Pages

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.